LeadIQ logo
Learn more at LeadIQ.com
REGENXBIO

REGENXBIO Employee Directory

Biotechnology ResearchMaryland, United States201-500 Employees

REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the development of AAV Therapeutics, an innovative class of gene therapy medicines. REGENXBIO is advancing a pipeline of AAV Therapeutics for retinal and rare diseases, including ABBV-RGX-314 for the treatment of wet AMD and diabetic retinopathy, being developed in collaboration with AbbVie, RGX-202 for the treatment of Duchenne and RGX-121 for the treatment of MPS II. Thousands of patients have been treated with REGENXBIO’s AAV Therapeutic platform, including Novartis’ ZOLGENSMA for children with spinal muscular atrophy. Designed to be one-time treatments, AAV Therapeutics have the potential to change the way healthcare is delivered for millions of people.

Find REGENXBIO employees' phone numbers or email addresses

REGENXBIO Global Highlights

Location
Employees

North America
608

Minus sign iconPlus sign icon
  • United States Of America
    607
  • Canada
    1

Europe
5

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    4
  • Belgium
    1

Asia
3

Minus sign iconPlus sign icon
  • Saudi Arabia
    1
  • Bangladesh
    1
  • Singapore
    1

REGENXBIO's Leadership

REGENXBIO Employee Metrics

100%
50%
0%
2024
2023
  • Research
  • Engineering
  • Manufacturing
  • Operations
  • Program & Project Management
  • Other

Contact profiles from REGENXBIO

Name
Title
Contact Info
Location
Last Update

Frequently Asked Questions

What is REGENXBIO known for?

Minus sign iconPlus sign icon
REGENXBIO was founded in 2008 operates in the Biotechnology Research industry. The company's main headquarters is located in 9804 Medical Center Dr Rockville, Maryland 20850 US; you can contact the main corporate office by phone at . Explore REGENXBIO's company overview page for more information.

What is REGENXBIO's most common email format?

Minus sign iconPlus sign icon
REGENXBIO employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more REGENXBIO email formats with LeadIQ.

How many employees does REGENXBIO have currently?

Minus sign iconPlus sign icon
REGENXBIO has approximately 360 employees as of November 2024. These team members are located across 3 continents, including North AmericaEuropeAsia.

Who are REGENXBIO's key employees and leadership?

Minus sign iconPlus sign icon

As of November 2024, REGENXBIO's key employees include:

  • Chief Scientific Officer: O. D.
  • Chief Medical Officer: S. P.
  • Chief Communications & People Officer: S. F.
  • Chief Medical Officer: R. R.
  • Vice President - Clinical Development & Operations, Patient Advocacy | Rare Diseases: P. F.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.